Table 1.
Characteristics of Families with Melanoma
| Sample Site | Phase | No. ofFamiliesper Site | Average No.of AffectedIndividualsper Family(Range) | Average No.of AffectedIndividualsTyped perFamily(Range) | Average Ageat Diagnosisin Years perFamily (Range) |
| Queensland Institute of Medical Research, Brisbane, Australia | 1 | 27 | 4.5 (3–8) | 3.9 (3–7) | 45.5 (29.7–76) |
| Westmead Institute for Cancer Research, Sydney, Australia | 1 | 22 | 4.1 (3–7) | 3.6 (3–6) | 43.8 (24–65) |
| Queensland Institute of Medical Research, Brisbane, Australia | 2 | 9 | 4.2 (3–8) | 3.2 (3–4) | 46.6 (30–58.6) |
| Westmead Institute for Cancer Research, Sydney, Australia | 2 | 15 | 3.7(3–8) | 3.4 (3–7) | 44.3 (28.8–62.7) |
| Genetic Epidemiology Branch, National Cancer Institute, Bethesda, U.S.A. | 2 | 2 | 4.5 (3–6) | 3.5 (3–4) | 41.9 (38.8–45) |
| Leiden University Medical Center, Leiden, The Netherlands | 2 | 2 | 5.5 (5–6) | 5.5 (5–6) | 43.9 (39.3–48.4) |
| Cancer Research UK, Leeds, U.K. | 2 | 2 | 3 | 3 | 44.3 (27.3–61.3) |
| Institut Gustave Roussy, Villejuif, France | 2 | 1 | 5 | 4 | 41.2 |
| University Hospital, Lund, Sweden | 2 | 1 | 5 | 4 | 54.6 |
| Karolinska Hospital, Stockholm, Sweden | 2 | 1 | 3 | 3 | 49 |